This year, the UK Stroke Assembly North event was held in Manchester. On day two, the morning plenary was all about stroke research, including how patients can get involved in shaping it.
Stroke Association has been shortlisted for Sainsburys’ Charity of the Year across the UK. We need your votes to secure these partnerships to enable us to support more stroke survivors and families affected by stroke.
This year, June 2018, we have teamed up with other UK aphasia organisations and will be supporting the work of member organisations of the Aphasia Alliance, of which the Stroke Association is one.
People with stroke due to brain haemorrhage have swelling around the haemorrhage on their brain scan. More swelling worsens recovery. No treatment improves outcome after this swelling.
The programme will use biological information about cells and molecules, and information from patients, to design a study of treatment for swelling after brain haemorrhage.
Existing vision tests do not tell us how a patient’s life will be influenced by their vision problems. This project aims to understand how the results of vision tests relate to how stroke survivors will be able to function in their daily lives.
Stroke survivors and their relatives consistently ask for information about how much recovery can be expected. This study will look at how well a patient can use their arm after stroke, and at their brain images recorded within 72-hours after stroke. The hope is that brain images can improve our prediction of patient arm movement recovery at six months after stroke.
Although speech and language therapists (SLTs) may help aphasia patients with their rehabilitation, there remains a clear lack of evidence-based treatments available for them to help their patients with problems of everyday talking, known as ‘discourse’. This study aims to address both the need for evidence-based treatments and improvement of clinical expertise to address discourse problems af
This study will investigate whether early initiation of direct anticoagulant drugs will be as safe as later initiation in stroke patients with an abnormal heart rhythm (atrial fibrillation). It will also investigate whether early initation could lead to fewer recurrent strokes.
People who have survived a previous stroke or transient ischaemic attack (TIA) are at particularly high risk of subsequent, ‘recurrent’ stroke with 30% having another stroke in the following five years. High blood pressure is the most important reversible risk factor for having a recurrent stroke.
The aim of this research programme is to develop a human brain bank to support biomedical research into the pathophysiology of human SVD that may be used nationally and internationally.